# Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion

Study · id `cardio:ct-nct03827915` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03827915](<https://clinicaltrials.gov/study/NCT03827915>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03827915

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT03827915. Randomized; no masking; primary purpose treatment. Start 2019-01-21 (actual); primary completion 2024-01-21 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT03827915, source copy `cardio:ctgov-nct03827915-2019-02-04`, retrieved 2026-10-26)
- Started: 2019-01-21 (actual) (ClinicalTrials.gov record NCT03827915, source copy `cardio:ctgov-nct03827915-2019-02-04`, retrieved 2026-10-26)
- Primary completion: 2024-01-21 (anticipated) (ClinicalTrials.gov record NCT03827915, source copy `cardio:ctgov-nct03827915-2019-02-04`, retrieved 2026-10-26)
- Completion: 2024-01-21 (anticipated) (ClinicalTrials.gov record NCT03827915, source copy `cardio:ctgov-nct03827915-2019-02-04`, retrieved 2026-10-26)
- Countries: Lebanon (ClinicalTrials.gov record NCT03827915, source copy `cardio:ctgov-nct03827915-2019-02-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03827915-2019-02-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion
- Condition: Atrial Fibrillation
- Condition: Defibrillators
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): Double sequential external defibrillation
- Lead sponsor: American University of Beirut Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 0665afc9e679fcbfc0f0683c3d4c3f7d52eef6f553de7e50608f0885962bf988
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
